| [1] |
QIAN Lingjiao, GAO Min, JIN Xiaobo, GUO Huijuan, RONG Hongguo, LU Yan.
Visualization Analysis on Research Related to Children Qingfei Oral Liquid Based on CiteSpace
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(2): 106-106-111.
|
| [2] |
WANG Ao, GUO Li, CHENG Gang, LIU Xiaoli.
Comparative Study of OTC Active Pharmaceutical Ingredient Management Systems in China and the United States
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(2): 151-151-155.
|
| [3] |
NIU Jiezhen, ZHANG Yuanqing, HAN Hongsheng, HE Ju, LV Juan, XIA Guozhi.
Study on the Applicability of Microbial Limit Test Methods for Licorice Decoction Pieces with Homology of Medicine and Food
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(2): 124-124-127.
|
| [4] |
TAN Tianqing, CHEN Wei, LU Xiaobing, LI Lei, WANG Lin, CAO Liu.
Determination of Related Substances in the Raw Material of Bevantolol Hydrochloride by HPLC and Methodological Validation
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(2): 117-117-123.
|
| [5] |
WANG Fengge, YANG Bingwei.
Impact of Xuesaitong Injection as Adjuvant Therapy on Cerebral Hemodynamics and Levels of Nerve-Related Factors in Patients with AIS-LVO
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(2): 138-138-142.
|
| [6] |
YANG Lu, WU Dongwan, CHEN Xiaoxiao.
Effect of Anlotinib on the VEGF/VEGFR Pathway and Clinical Benefits in Refractory Differentiated Thyroid Cancer
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(2): 133-133-137.
|
| [7] |
NIAN Yongqi, WANG Yongming, SHI Chunlan, CHENG Xiaoping, LIU Xueliang, WANG Yongjing, HAN Tianchu, HAN Dabin.
Research on Evaluation and Improvement Strategies for Inspection and Testing Capabilities of Pharmaceutical Manufacturing Enterprises in Qinghai Province
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(2): 81-81-85.
|
| [8] |
ZHANG Bin, GAO Huijun.
Effect of Qingjin Huatan Decoction on the Nrf2/HO-1 Signaling Pathway and Symptom Recovery in Chronic Obstructive Pulmonary Disease
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(2): 128-128-132.
|
| [9] |
SHI Chunlan, NIAN Yongqi, WANG Yongming, LIU Xueliang, CHENG Xiaoping, WANG Yongjing, QI Yankai, HAN Dabin.
Common Problems and Analysis of Tibetan Medicine Preparation Filing in Medical Institutions in Qinghai Province
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(2): 86-86-89.
|
| [10] |
JIAN Yifei, TANG Kejing, XUE Xiaoyan, ZHANG Peng, WANG Congrong, GAO Yongbo, BIAN Xiaolan, XUAN Jianwei.
Cost-Benefit Analysis of Closed-System and Open-System Infusion of Human Serum Albumin in ICU Patients
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(2): 143-143-150.
|
| [11] |
LIANG Lvyuan, CAO Jialei, WANG Yiping, WEI Xinyu, ZHANG Zhenyu, LIU Puyu, KANG Jing, KANG Mingxuan, DANG Weili, MA Bingxiang.
Research on the Modern Medication Rules of Rhizoma Dioscoreae Based on "Disease-Medicine-Dosage" and Its Application in Diabetic Kidney Disease
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(2): 90-90-105.
|
| [12] |
DONG Yu, LIU Jing, JIANG Xin, WANG Zhenhong.
Determination of Bisphenol A in Pharmaceutical Packing Materials by High Performance Liquid Chromatography-Tandem Mass Spectrometry
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(2): 112-112-116.
|
| [13] |
LI Xu, HE Xiaoyu, ZHAO Pinghua, SHANG Xiaoyan.
Uncertainty Evaluation and Z-Value Analysis for Determination of the Content of Stilbene Glucoside in Proficiency Testing Samples of Polygonum multiflorum by HPLC
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 18-18-23.
|
| [14] |
DAI Qi, GUI Ziya, DONG Zhaowei, YE Qiaobo, LUO Xiao, ZHANG Liang.
Research Progress on the Active Constituents of Cratargi Fructus and Their Mechanism of Action in Treating Nonalcoholic Fatty Liver Disease
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 39-39-45.
|
| [15] |
CHENG Qianqian, ZHANG Yali.
Investigation on Medication Adherence in Elderly Patients with Multiple Chronic Diseases and Its Related Factors
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 77-77-80.
|